BioParkDx Inc.

27, Gongneung-ro 58-gil, Nowon-gu
Seoul,  01809

Korea (South)
https://www.bioparkdx.com

• Booth: 1860

We - are Manufacturer & Distributor - deal with IVD medical devices and reagents - are founded 2014 - have strength in sales network in Korea

 Press Releases

• [POC PCR] Pipette-based technology overcomes microfluidic's limit (Apr 28, 2024)
  This is the excerpt from the article. 
  For the full text, please refer to the link.
  
  Date 22nd/Mar/2024
  
  CEO Kim thought that developing a competitive diagnosis platform requires a different approach from the existing fluid control method using microfluids. The most of diagnosis platforms use the method of transferring 10 microliters of fine fluid through a very thin tube to implement a sealed environment. Actually, in many field of diagnosis, it has made the structure complicated and precise control difficult.
  
  Then he started research and finally figured out that applying the pipetting method to POC PCR diagnosis platform could be a solution to, considering its potential which is being used for large-scale automation equipment. As a result, it succeeded in developing a platform called "MoiM Dx100" that applies a new pipetting method that is also possible for the field diagnosis platform and cartridge design for it. The failure rate of the test is less than 2% compared to that of large automation equipment, which is more reliable than the on-site diagnosis platforms of global leading companies, which are around 5-7%, as well as the cost of cartridges is half. Another strength is that it can multiple-diagnose up to 16 types of viruses in a small size of 10cm wide, and the test time is only 40 minutes.

 Additional Info